tramadol hydrochloride

FDA Drug Profile — tramadol hydrochloride, Tramadol Hydrochloride Extended-Release, ConZip, Tramadol Hydrochloride

tramadol hydrochloride is listed in the FDA National Drug Code directory with 20 NDC codes, marketed under brand names including tramadol hydrochloride, Tramadol Hydrochloride Extended-Release, ConZip. Available dosage forms: tablet, capsule, capsule, extended release, solution.

Drug details

Generic Name
tramadol hydrochloride
Brand Names
tramadol hydrochloride, Tramadol Hydrochloride Extended-Release, ConZip, Tramadol Hydrochloride
Application Number
ANDA202075
Sponsor
REMEDYREPACK INC.
NDC Codes
20
Dosage Forms
TABLET, CAPSULE, CAPSULE, EXTENDED RELEASE, SOLUTION
Routes
ORAL
Active Ingredients
TRAMADOL HYDROCHLORIDE

Indications and Usage

1 INDICATIONS AND USAGE Tramadol hydrochloride tablets are indicated in adults for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. Limitations of Use Because of the risks of addiction, abuse, misuse, overdose and death with opioids, which can occur at any dosage or duration and persist over the course of therapy [see Warnings and Precautions (5.2)] , reserve opioid analgesics including tramadol hydrochloride tablets for use in patients for whom alternative treatment options are ineffective, not tolerated, or would be otherwise inadequate to provide sufficient management of pain. Tramadol hydrochloride tablets are an opioid agonist indicated in adults for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. Limitations of Use Because of the risks of addiction, abuse, misuse, overdose, and death which can occur at any dosage or duration and persist over the course of therapy, reserve opioid analgesics including tramadol hydrochloride tablets, for use in patients for whom alternative treatment options are ineffective, not tolerated, or would be otherwise inadequate to provide sufficient management of pain. (1, 5.2)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.